Biota Adds Megan Glover And Steve Kloos To Board

Biota has appointed water industry executives Megan Glover and Steve Kloos to its Board of Directors as the company prepares to commercialize rapid PFAS testing technology. The appointments follow Biota’s $3 million seed financing.

Glover founded water quality technology company 120Water and currently serves as Chief Digital Officer at Usalco. Kloos is a partner at water technology investment firm Burnt Island Ventures, which led Biota’s seed round.

Preparing PFAS Testing For Commercial Deployment

Biota is developing field-deployable technology intended to provide actionable PFAS test results in less than an hour.

Conventional laboratory testing can create delays between sample collection and results. Biota believes faster testing could help water operators and environmental professionals make more timely decisions.

Its technology remains in development, and commercial performance will depend on validation, reliability across different sample conditions, customer adoption and relevant regulatory requirements.

Glover will contribute experience in go-to-market strategy and building technology for utilities and government agencies.

Kloos holds a doctorate in chemistry and brings experience from GE Water, venture investing, intellectual property strategy and technology commercialization.

KEY QUOTES:

We’re at an exciting inflection point for Biota. We’ve built a strong scientific foundation and demonstrated the need for a fundamentally faster approach to PFAS testing. Now our focus is on bringing that technology to market and scaling its impact. Megan has successfully navigated the exact stage of growth we’re entering, while Steve brings an exceptional combination of scientific depth, intellectual property expertise, and investment experience. I couldn’t be more excited to have them helping shape Biota’s future.

Rose Nash, Founder and CEO of Biota

Building a successful company in the water industry takes more than great technology. It requires a deep understanding of customers and how to bring innovation into an industry that has historically been slow to adopt. Biota is addressing a critical unmet need with a compelling technology platform that must exist in the market. I’m excited to work with Rose and the team to turn that opportunity into widespread commercial adoption.

Megan Glover, Director at Biota

PFAS is an enormous environmental problem, and one of the biggest issues is the lack of timely, affordable testing. What drew us to Biota was their customer-first approach and differentiated, patent-pending technology that performs in challenging real-world samples. Biota has the potential to fundamentally change how the industry monitors PFAS, and I’m excited to help the team realize that vision.

Steve Kloos, Director at Biota